H15.84

Clinical Causes: Genetic predisposition or inherited connective tissue disorders such as Marfan syndrome or Ehlers-Danlos syndrome. Previous eye surgeries or trauma that weaken the scleral tissue. Inflammatory eye conditions like scleritis or uveitis that damage scleral tissue. Degenerative diseases or conditions associated with aging that lead to scleral thinning. Certain inflammatory or autoimmune disorders that affect ocular tissues.

Key Symptoms: A visible bulging or thinning area on the sclera, often noticeable around the eyeball. Changes in eye shape, which may affect visual perception. Discomfort or light sensitivity (photophobia) in some cases. In rare instances, pain or redness if associated with inflammatory conditions. Potential changes in vision, including blurring or distortion, if the ectasia impacts the optical structures.

Diagnosis Path: Visual inspection to identify any outward bulging or thinning of the sclera. Ultrasound biomicroscopy or anterior segment optical coherence tomography (OCT) to measure scleral thickness. Assessment of eye shape and structure through imaging techniques like slit-lamp examination. Review of medical history to identify any underlying conditions or previous eye trauma. Additional tests if an autoimmune or genetic condition is suspected.

Treatment Protocols: Monitoring to observe the progression of scleral thinning over time. Use of scleral patches or grafts in severe cases to reinforce the scleral wall. Management of underlying conditions, such as controlling inflammation or autoimmune activity. Surgical procedures to repair or reshape the sclera if significant deformation occurs. Vision correction options such as glasses or contact lenses if visual distortion is present. Regular follow-up with an eye specialist to monitor eye health and prevent further deterioration.